|

Cyclophosphamide and fludarabine Clinical Trials

2 actively recruiting trials

▲ +1 trial since May 2026

Pipeline

Early 1: 1Phase 1: 1

Top Sponsors

  • Tongji Hospital1
  • Shanghai Zhongshan Hospital1

Indications

  • Cancer2
  • POEMS Syndrome1
  • Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)1
  • Cholangiocarcinoma, Intrahepatic1
  • Cholangiocarcinoma, Perihilar1

Other2 trials

Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer
Phase 1
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.